Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Account Payables
Amounts the company owes suppliers for goods and services received.
Account Payables history
Currency unavailable · from the balance sheet
No Account Payables data reported for this period type.
Account Payables vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $428.93M USD | +479.2% | +16.6% | 20.4% | |
| Mar 2026 | $16.14M USD | +220.3% | -6.5% | 2.2% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 2.06M SEK | — | — | 2.2% |
| Mar 2026 | $265K USD | +117.2% | +0.5% | 0.2% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +220.3% | +0.5% | 2.2% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.